**5. Conclusion**

Over the past few decades, technological advancements in mass spectrometer enabled it to surpass other detection platforms and evolve as an indispensable analytical tool to support the bioanalytical needs of drug discovery and development. Current generation mass spectrometers could efficiently handle both qualitative and quantitative aspects of bioanalysis. Additionally, the likelihood of hyphenation of mass spectrometers with ultrafast liquid chromatography systems, extended its applications to high throughput bioanalysis. Even though significant achievements were made in the past, instruments will continue to get more and more sensitive and become better acquiescent to automation.

**57**

**Author details**

Vijayabhaskar Veeravalli1

and Pratima Srivastava<sup>2</sup>

*Mass Spectrometry as a Workhorse for Preclinical Drug Discovery: Special Emphasis on Drug…*

\*, Lakshmi Mohan Vamsi Madgula1

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

1 Syngene International Limited, Biocon Park, SEZ, Bangalore India

2 GVK BIO Pvt Ltd, Hyderabad, Telangana, India

\*Address all correspondence to: vveerav1@jhmi.edu

provided the original work is properly cited.

*DOI: http://dx.doi.org/10.5772/intechopen.88385*

*Mass Spectrometry as a Workhorse for Preclinical Drug Discovery: Special Emphasis on Drug… DOI: http://dx.doi.org/10.5772/intechopen.88385*
